Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jan J CornelissenBob Löwenberg

Abstract

To determine to what extent allogeneic hematopoietic stem-cell transplantation (alloHSCT) quantitatively reduces relapse in acute myeloid leukemia with monosomal karyotype (MK-AML) compared with alternative postremission therapy and how it compares with other cytogenetic subcategories. Of 2,560 patients (younger than age 61 years) without core-binding factor abnormalities including 305 patients with MK-AML receiving first-line induction treatment, 1,975 patients (77%) achieved remission, and 1,588 received consolidation in the first complete remission (CR1) after two induction cycles. Consolidation treatment of 107 patients with MK-AML consisted of alloHSCT (n = 45), chemotherapy (n = 48), or autologous HSCT (n = 14). The 5-year overall survival after start of consolidation was 19% for patients with MK-AML who received alloHSCT and 9% for those who received chemotherapy or autoHSCT (P = .02). Relapse-free survival (RFS) at 5 years was 17% versus 7% (P = .003). Cox regression analysis was performed with alloHSCT as a time-dependent covariate. Hazard ratios (HRs) associated with alloHSCT for relapse and RFS were 0.30 (95% CI, 0.24 to 0.37; P < .001), and 0.52 (95% CI, 0.43 to 0.62; P < .001), respectively. HRs were similar in MK-...Continue Reading

References

Dec 13, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B LöwenbergW L van Putten
Aug 22, 2003·The New England Journal of Medicine·Bob LöwenbergUNKNOWN Swiss Group for Clinical Cancer Research
Mar 11, 2004·Blood Reviews·Krzysztof MrózekClara D Bloomfield
Dec 21, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·André SchrauderMartin Schrappe
Aug 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitri A BreemsBob Löwenberg
Sep 25, 2009·The New England Journal of Medicine·Bob LöwenbergUNKNOWN Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group
Dec 17, 2009·Hematology·David Grimwade, Robert K Hills
Dec 30, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan K BurnettKeith Wheatley
Jun 18, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Betul OranDaniel Weisdorf

❮ Previous
Next ❯

Citations

Aug 21, 2013·Current Oncology Reports·John Magenau, Daniel R Couriel
Jul 9, 2013·Blood Cancer Journal·S S KenderianM M Patnaik
Dec 10, 2013·Hematology·Charles Craddock
May 18, 2013·Iranian Red Crescent Medical Journal·Ardeshir GhavamzadehMohammad Jahani
Dec 3, 2014·Hematology/oncology Clinics of North America·Tsila Zuckerman, Jacob M Rowe
Jan 20, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Gary J SchillerPinkal Desai
Feb 19, 2014·Current Opinion in Immunology·Simrit Parmar, David S Ritchie
Sep 4, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marcelo C PasquiniDaniel J Weisdorf
Feb 11, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Marjan CruijsenGerwin Huls
Jun 11, 2015·American Journal of Hematology·Daniela DamianiRenato Fanin
Oct 17, 2015·Blood Cancer Journal·J E JangUNKNOWN Korean Society of Hematology AML/MDS Working Party
Jan 16, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Xiao-Fei YangDe-Pei Wu
Jan 11, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Aaron T GerdsBart L Scott
May 9, 2014·Blood·Minoo Battiwalla
Feb 22, 2014·Blood·Matteo G Della PortaUNKNOWN Gruppo Italiano Trapianto di Midollo Osseo
Dec 18, 2014·Blood·Gert Ossenkoppele, Bob Löwenberg
May 21, 2016·Leukemia·A G DinmohamedM Jongen-Lavrencic
Nov 9, 2016·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kazuhiro NishikawaIchinosuke Hyodo
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tilmann BochtlerAlwin Krämer
Jan 19, 2017·Current Opinion in Hematology·Sabine BlumMichael Lübbert
Dec 8, 2017·Journal of Internal Medicine·C CraddockUNKNOWN Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and HOVON-SAKK
Dec 27, 2018·Current Opinion in Hematology·Charles Craddock, Manoj Raghavan
Jan 17, 2015·Current Opinion in Hematology·Ofir Wolach, Richard M Stone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.